Periphagen Holdings periphagen.com


Public lists: Pharma Startups (4732)

PeriphaGen is a biopharmaceutical company whose corporate objective is the development of first in class neuronal gene delivery products for neurologic disorders with significant unmet medical need. The intuitive way to treat conditions that directly affect neurons is to target treatment to the neurons themselves. PeriphaGen's first indications of interest are neuropathic pain, neuropathy, and neuronal regeneration. The PeriphaGen NEuronal Therapeutics (NET) platform based drug candidates have t...Show all

PeriphaGen is a biopharmaceutical company whose corporate objective is the development of first in class neuronal gene delivery products for neurologic disorders with significant unmet medical need. The intuitive way to treat conditions that directly...Show all

Company (Alive / Active)

Phone: 412-488-0348

Fax:

2100 Wharton Street
Suite 701
Pittsburgh, 15203
Pennsylvania, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Periphagen Holdings $6.5M Mar 31, 2014

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Periphagen Holdings Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Undisclosed InvestorsOtherUnattributed
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)